Efficacy and Safety of Lenalidomide in Patients With IgG4-Related Disease
Efficacy and Safety of Lenalidomide in Patients With IgG4-Related Disease
Not yet recruiting · NCT07719543 · Registry updated 2026-07-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Lenalidomide in Patients With IgG4-Related Disease | Immunoglobulin G4-Related Disease, autoimmune disease, immune system disorder | Not yet recruiting | Phase 3 | 2026-07-22 | NCT07719543 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing SL Pharmaceutical Co., Ltd. | 1 |
| Chinese PLA General Hospital | 238 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| General Hospital of Central Theater Command | Wuhan | China | 1 |
| Hainan Hospital of Chinese PLA General Hospital | Sanya | China | 1 |
| The First Medical Center of Chinese PLA General Hospital | Beijing | China | 3 |